Related Experiment Video
Updated: Mar 11, 2026
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
Discovery and biological characterization of potent myeloid cell leukemia-1 inhibitors
Taekyu Lee1, Zhiguo Bian1, Bin Zhao1
1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Abstract:
Myeloid cell leukemia 1 (Mcl-1) is an antiapoptotic member of the Bcl-2 family of proteins that when overexpressed is associated with high tumor grade, poor survival, and resistance to chemotherapy. Mcl-1 is amplified in many human cancers, and knockdown of Mcl-1 using RNAi can lead to apoptosis. Thus, Mcl-1 is a promising cancer target. Here, we describe the discovery of picomolar Mcl-1 inhibitors that cause caspase activation, mitochondrial depolarization, and selective growth inhibition. These compounds represent valuable tools to study the role of Mcl-1 in cancer and serve as useful starting points for the discovery of clinically useful Mcl-1 inhibitors.
Pdb Id Codes:
Comp. 2: 5IEZ; Comp. 5: 5IF4.
Insights
Researchers discovered potent Mcl-1 inhibitors that induce cancer cell death. These novel compounds target Mcl-1 (myeloid cell leukemia 1), a protein implicated in cancer progression and drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Myeloid cell leukemia 1 (Mcl-1) is an anti-apoptotic protein frequently overexpressed in various human cancers.
- Mcl-1 overexpression correlates with high tumor grade, poor patient survival, and chemoresistance.
- Targeting Mcl-1 is a promising strategy for cancer therapy due to its role in promoting cancer cell survival.
Discussion:
- The study reports the discovery of novel small molecules with picomolar affinity for Mcl-1.
- These inhibitors effectively induce apoptosis, evidenced by caspase activation and mitochondrial depolarization.
- Selective growth inhibition of cancer cells was observed, highlighting the specificity of these compounds.
Key Insights:
- Discovery of high-affinity Mcl-1 inhibitors.
- Demonstration of Mcl-1 inhibition leading to cancer cell apoptosis and growth arrest.
- Identification of specific Mcl-1 inhibitors (Comp. 2: 5IEZ; Comp. 5: 5IF4).
Outlook:
- These Mcl-1 inhibitors serve as valuable chemical probes for further research into Mcl-1's role in cancer.
- The identified compounds represent promising starting points for the development of novel anti-cancer therapeutics.
- Further optimization could lead to clinically applicable drugs targeting Mcl-1-dependent cancers.
